Quarterly Call Option Transactions in Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR) during . The information is specifically focused on institutions that hold call options of Esperion Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 268,100 | 37,902 | 306,002 | 0 | 10,000 | 10,000 | 296,002 | |
| Q4 2021 | 29,900 | 18,900 | 48,800 | 167,400 | 25,600 | 193,000 | -144,200 | |
| Q1 2022 | 266,300 | 0 | 266,300 | 0 | 14,900 | 14,900 | 251,400 | |
| Q2 2022 | 508,400 | 0 | 508,400 | 0 | 26,500 | 26,500 | 481,900 | |
| Q3 2022 | 105,000 | 1,243,600 | 1,348,600 | 71,900 | 0 | 71,900 | 1,276,700 | |
| Q4 2022 | 2,560,300 | 1,328,100 | 3,888,400 | — | 3,888,400 | |||
| Q1 2023 | 583,700 | 6,310 | 590,010 | 1,508,400 | 0 | 1,508,400 | -918,390 | |
| Q2 2023 | — | 954,100 | 0 | 954,100 | -954,100 | |||
| Q3 2023 | 4,000 | 0 | 4,000 | 190,400 | 0 | 190,400 | -186,400 | |
| Q4 2023 | 957,900 | 665,400 | 1,623,300 | 537,300 | 0 | 537,300 | 1,086,000 | |
| Q1 2024 | 873,200 | 65,590 | 938,790 | 491,200 | 0 | 491,200 | 447,590 | |
| Q2 2024 | 494,100 | 428,700 | 922,800 | 231,650 | 0 | 231,650 | 691,150 | |
| Q3 2024 | 35,600 | 69,200 | 104,800 | 753,900 | 0 | 753,900 | -649,100 | |